Initially, the accumulation of Aβ1–42 causes an increase in Nrf2 levels, reflecting a protective cellular response to ROS, but up-regulation of Keap1 also by Aβ1–42 ultimately blocks Nrf2 activity, thus contributing to the progression of AD [103]. This evidence concerns the gene NFE2L2 and Alzheimer disease.